Phase 2 Interstitial Lung Disease Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have a lung condition called IPF (idiopathic pulmonary fibrosis) and previously completed a full course of treatment with a drug called HSK44459 in an earlier study, without stopping the treatment early for permanent reasons
- The medical team running the trial has assessed that the potential benefits of continuing HSK44459 treatment outweigh the risks for you personally
Who may not be able to join:
- You are planning to have a lung transplant
- You have a low body weight (BMI under 18.5) and experienced unexplained weight loss of more than 10% during the previous study
- You have been diagnosed with any form of cancer in the last 5 years before the screening appointment
- You have a history of depression or an anxiety disorder
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 18036618841
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
The incidence and severity of adverse events during the study period
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.